Patent · US Active

Crystalline forms of CFTR modulators

US12319693B2 · kind B2 · utility

0Cited by
21References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 2023
Grant dateJun 3, 2025
Priority date—
Expiry dateOct 24, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Crystalline forms of Compound I: pharmaceutically acceptable salts thereof, and solvates and hydrates thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.